Search

Your search keyword '"Montemaggi A"' showing total 49 results
Start Over Author "Montemaggi A" Publisher elsevier bv
49 results on '"Montemaggi A"'

1. Gait deviation index to quantify the short-term effects of functional surgery on walking kinematics in patients with cerebral palsy. A prospective cohort study

Author

Basini, G., primary, Prati, P., additional, Zerbinati, P., additional, Rambelli, C., additional, Galletti, M., additional, Bemporad, J., additional, Mascioli, F., additional, Montemaggi, P., additional, Ehsani, A., additional, Vetrano, M., additional, Merlo, A., additional, and Mazzoli, D., additional

Published
2023
Full Text
View/download PDF

3. Private and Public Enforcement of EU Investor Protection Regulation

Author

Federico Della Negra, Giorgio Afferni, Mads Andenas, Filippo Annunziata, Stefano Montemaggi, and Raffaele D’Ambrosio

Subjects
Market economy, business.industry, Financial market, Duty of care, Legislation, Context (language use), business, Investment (macroeconomics), Enforcement, Financial services, Best execution
Abstract

Overtime, some of the core provisions that traditionally identify, in the context of MiFID, the investors’ protection regime, have become a template for the protection of consumers and “end-users” of financial services and products in other areas of EU Legislation. Those same provisions – whose pivot are the overreaching rules on the duty of care, suitability, conflicts of interest, inducements, best execution – gradually evolved from being specific to the investment services regime, to becoming widespread standards that inspire EU Legislation in other sectors. This paper will show, first of all, how this phenomenon actually evolved, and how MiFID standards are effectively challenging the still prevailing sectoral approach followed, in the EU, with regards to financial markets regulation. Some of the main consequences of the expansion of the MiFID regime will also be discussed, including those that relate to enforcement and judicial protection; ultimately, some conclusions will be drawn, and a few suggestions will be set out for future analysis.

Published
2020

5. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma

Author

Guido Costamagna, Pasquale Marano, Gabriella Brizi, Vincenzo Perri, Massimiliano Mutignani, Alessio G. Morganti, Montemaggi P, Numa Cellini, and Ralph R. Dobelbower

Subjects
Male, Cancer Research, medicine.medical_specialty, Palliative care, medicine.medical_treatment, Brachytherapy, Bile Duct Neoplasm, Bile Duct Carcinoma, Bile Ducts, Extrahepatic, Humans, Medicine, Radiology, Nuclear Medicine and imaging, Aged, Aged, 80 and over, Cholestasis, Radiation, Endoscopic retrograde cholangiopancreatography, medicine.diagnostic_test, Common bile duct, business.industry, Palliative Care, Middle Aged, Surgery, Pancreatic Neoplasms, Radiation therapy, medicine.anatomical_structure, Bile Duct Neoplasms, Oncology, Biliary tract, Female, business
Abstract

Purpose : A new method of palliation of malignant obstructive jaundice is presented. Methods and Materials : Twelve patients with carcinoma of the extrahepatic bile ducts (EHBD-five patients) or pancreatic head (PH-seven patients) received radiation therapy between 1988 and 1991. Percutaneous transhepatic biliary drainage was performed in four EHBD patients and an endoprosthesis was placed during endoscopic retrograde cholangiopancreatography (ERCP) in the other eight patients. All 12 received intraluminal brachytherapy (ILBT) : 20-50 Gy calculated at 1 cm from the Iridium-192 ( 192 Ir) wire. In four PH patients the source was placed in the duct of Wirsung ; in the other eight patients ILBT was performed via the common bile duct. Five of the seven PH patients and one of the five EHBD patients received External Beam Radiation Therapy (EBRT) : 26-50 Gy, alone or with concomitant 5-Fluorouracil (5-FU). Results : Cholangitis occurred in six patients. Three PH patients treated with EBRT + ILBT developed gastrointestinal toxicities. With a minimum follow-up of 18 months, median survival times were 14 months (EHBD) and 11.5 months (PH) ; one of the seven PH patients is alive (29 months) and two of the EHBD patients are alive (18 and 43 months). All patients had satisfactory control of jaundice. Conclusions : The results in the EHBD patients suggest that the addition of ILBT after biliary drainage prolongs survival. Further experience is necessary to determine whether ILBT in the common bile duct and/or in the duct of Wirsung may be, in PH patients, an alternative boost technique to Interstitial Brachytherapy (IBT) or Intraoperative Electron Beam Radiation Therapy (IOEBRT).

Published
1995

6. Interstitial brachytherapy for pancreatic cancer: Report of seven cases treated with 125 I and a review of the literature

Author

Ralph Dobelbower, Alessio G. Morganti, Stefano Luzi, Francesco Caracciolo, Francesco Crucitti, Montemaggi P, Numa Cellini, and Daniela Smaniotto

Subjects
Male, Cancer Research, medicine.medical_specialty, Exacerbation, medicine.medical_treatment, Fistula, Brachytherapy, Adenocarcinoma, Iodine Radioisotopes, Pancreatic cancer, medicine, Humans, Radiology, Nuclear Medicine and imaging, Survival analysis, Aged, Radiation, business.industry, Cancer, Middle Aged, medicine.disease, Surgery, Pancreatic Neoplasms, Radiation therapy, Oncology, Female, business
Abstract

Since 1975, seven groups of investigators have reported clinical results of interstitial brachytherapy (IBT) for pancreatic cancer. The reports are comprised of data from 254 patients, 21 of whom died in the postoperative period for an overall operative mortality rate of 8.7%. Operative mortality rate range from 0% to 32% in individual reports. Most patients have been treated with 125I, although 25 patients were treated with 198Au seeds. Most investigators report combining IBT with external beam radiation therapy (EBRT) +/- adjuvant chemotherapy. In general, IBT has been associated with considerable morbidity. Median patient survival time has not exceeded 15 months. This report describes an additional seven patients with locally unresectable pancreatic cancer, without distant metastases, treated primarily with 60 to 100 Gy matched peripheral dose (MPD) by 125I IBT. One patient died postoperatively of a pulmonary embolus. Four of the remaining six patients were also treated with modest doses (10.5 to 30 Gy) of EBRT late in the course of the disease for local tumor progression. One developed a pancreaticocutaneous fistula, and one developed exacerbation of pre-existing diabetes mellitus. The median patient survival time from the date of IBT was 7 months (range: 0 to 21 months). One patient is alive without clinical evidence of cancer 9 months after IBT.

Published
1991

7. Local Control (LC) and Overall Survival (OS) With Concomitant Temozolomide (TM) and High Dose 'Shrinking Fields' Radiotherapy (SFHDRT) as Post Operative (PO) Treatment in Patients (pts) With Incomplete Resection (IR) of Glioblastoma (GBM)

Author

P. Montemaggi, M. Bono, V. Umina, P. Guerrieri, Laura La Paglia, and E. Tumminello

Subjects
Cancer Research, medicine.medical_specialty, Radiation, Temozolomide, business.industry, medicine.medical_treatment, medicine.disease, Incomplete Resection, Surgery, Radiation therapy, Oncology, Concomitant, medicine, Overall survival, Radiology, Nuclear Medicine and imaging, In patient, Post operative, business, medicine.drug, Glioblastoma
Published
2007

8. Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study

Author

Busetto, Mario, primary, Fusco, Vincenzo, additional, Corbella, Franco, additional, Bolzan, Mario, additional, Pavanato, Giovanni, additional, Bonetti, Bartolomea, additional, Maggio, Francesca, additional, Orsatti, Marco, additional, De Renzis, Costantino, additional, Mandoliti, Giovanni, additional, Sotti, Guido, additional, di Monale e Bastia, Michela Buglione, additional, Turcato, Giacomo, additional, Colombo, Sara, additional, Magrini, Stefano Maria, additional, Guglielmi, Rosa Bianca, additional, Cionini, Luca, additional, Montemaggi, Paolo, additional, Panizzoni, Gino, additional, Delia, Paolo, additional, Sciumé, Francesco, additional, Castaldo, Giovanni, additional, Matteucci, Francesco, additional, Loreggian, Lucio, additional, Sansotta, Guido, additional, and Lastrucci, Luciana, additional

Published
2013
Full Text
View/download PDF

11. EP-1255 POSTOPERATIVE RADIATION THERAPY IN CHILDREN WITH WILMS' TUMOR

Author

G. Evangelista, P. Montemaggi, A. Daidone, G. Caminiti, and A. Grillo

Subjects
medicine.medical_specialty, Oncology, business.industry, Postoperative radiation, Medicine, Radiology, Nuclear Medicine and imaging, Wilms' tumor, Hematology, Radiology, business, medicine.disease
Published
2012

18. Accelerated Hypofractionated Brachytherapy (AHFBRT) Regimen in Integrated Radiation Treatment (IT) for Advanced Cervical Cancer: Short Term Analysis of Local Control (LC) and Adverse Events (AE)

Author

K. Gallias, L. Moscadini, P. Guerrieri, F. D'Alia, and P. Montemaggi

Subjects
Cervical cancer, Cancer Research, medicine.medical_specialty, Radiation, business.industry, medicine.medical_treatment, Brachytherapy, medicine.disease, Surgery, Term (time), Regimen, Oncology, medicine, Radiology, Nuclear Medicine and imaging, business, Adverse effect
Published
2010

20. 148 poster: Local Control (LC) and Function Preservation (FP) by HDR-Brachytherapy (HDR-BRT) in Epithelial Tumors of Facial Region

Author

P. Guerrieri, G. Diana, P. Montemaggi, T. Cucchiara, L. Moscadini, A. Daidone, M. Bono, and M. Mangiapane

Subjects
medicine.medical_specialty, Oncology, business.industry, medicine.medical_treatment, Brachytherapy, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, Function preservation, business, Facial region, Surgery
Published
2009

28. In response to DRS. Mohan and Nori

Author

Paolo Montemaggi and Ralph R. Dobelbower

Subjects
Cancer Research, Radiation, Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, Theology, business
Published
1995

29. Combined modality treatment in unresectable extrahepatic biliary carcinoma

Author

Morganti, Alessio G., primary, Trodella, Lucio, additional, Valentini, Vincenzo, additional, Montemaggi, Paolo, additional, Costamagna, Guido, additional, Smaniotto, Daniela, additional, Luzi, Stefano, additional, Ziccarelli, Pierpaolo, additional, Macchia, Gabriella, additional, Perri, Vincenzo, additional, Mutignani, Massimiliano, additional, and Cellini, Numa, additional

Published
2000
Full Text
View/download PDF

30. The influence of benzylic protection and allylic substituents on the CuCl-TMEDA catalyzed rearrangement of N-allyl-N-benzyl-2,2-dihaloamides to γ-lactams. Application to the stereoselective synthesis of pilolactam

Author

Ghelfi, Franco, primary, Bellesia, Franco, additional, Forti, Luca, additional, Ghirardini, Gianluca, additional, Grandi, Romano, additional, Libertini, Emanuela, additional, Montemaggi, Maria C, additional, Pagnoni, Ugo M, additional, Pinetti, Adriano, additional, De Buyck, Laurent, additional, and Parsons, Andrew F, additional

Published
1999
Full Text
View/download PDF

31. 126Interstitial High Dose Rate Brachytherapy: Radiobiological and clinical points of view of multiple fractionation schedule in clinical practice

Author

L. Ziccarelli, M.A.M. Maria Angela Molinaro, F. Piro, P. Ziccarelli, A.D. Anna Destito, P. Guerrieri, Cataldo Bianco, P. Montemaggi, and R.M. Rosa Molè

Subjects
Clinical Practice, Schedule, medicine.medical_specialty, Oncology, business.industry, medicine, Radiology, Nuclear Medicine and imaging, Medical physics, Hematology, business, High-Dose Rate Brachytherapy
Published
2001

34. 28 Synergistic antiproliferative effects of ionizing radiations with anti-epidermal growth factor receptor monoclonal antibody C225 and protein kinase a antisense oligonucleotide hyb 165

Author

P. Montemaggi, Fortunato Ciardiello, P. Guerrieri, Cataldo Bianco, John Mendelsohn, Sudhir Agrawal, R. Bianco, and G. Tortora

Subjects
Cancer Research, Radiation, business.industry, medicine.drug_class, Monoclonal antibody, Ionizing radiation, Oncology, Antisense oligonucleotides, Anti-Epidermal Growth Factor Receptor, Cancer research, Medicine, Radiology, Nuclear Medicine and imaging, business, Protein kinase A
Published
1999

40. 112Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the Wirsung duct: A feasibility study

Author

P. Montemaggi, Ziccarelli P, O. Smaniotto, M.A. Gambacorta, M. Mutignani, V. Valentine, G. Costamagna, Numa Cellini, Stefano Luzi, and Alessio G. Morganti

Subjects
Oncology, medicine.medical_specialty, Unresectable Pancreatic Carcinoma, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Wirsung duct, Radiology, business, Intraluminal brachytherapy
Published
1998

46. 152 Intraluminal brachytherapy in a new strategy for unresectable extrahepatic bile duct and pancreatic cancer

Author

Luther W. Brady, Alessio G. Morganti, P. Guerrieri, P. Montemaggi, and G. Costamagna

Subjects
medicine.medical_specialty, Bile duct, business.industry, Hematology, medicine.disease, Gastroenterology, medicine.anatomical_structure, Oncology, Pancreatic cancer, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, CA19-9, Radiology, business, Intraluminal brachytherapy
Published
1996

49. 40 Preioperative brachytherapy in localized inoperable pancreatic cancer

Author

Daniela Smaniotto, Alessio G. Morganti, Stefano Luzi, Numa Cellini, O. Caspiani, and Montemaggi P

Subjects
Oncology, medicine.medical_specialty, business.industry, Internal medicine, medicine.medical_treatment, Pancreatic cancer, Brachytherapy, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease
Published
1994

Catalog

Books, media, physical & digital resources
See catalog results